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Background: Lifestyle plays an important role in the development of diabetic retinopathy. The lifestyle in
Guangzhou is different from other cities in China as the Cantonese prefer eating rice porridge, but not spicy foods.
The objectives of this study were to investigate the prevalence and determinants of diabetic retinopathy in a
high-risk population of Guangzhou.
Methods: Subjects (619 totals) aged over 45 years old, without known diabetes were recruited from five randomly
selected Guangzhou communities in 2009–2010. All participants were invited to complete the Finnish Diabetes Risk
Score (FINDRISC) questionnaire. Subjects with FINDRISC score≥ 9 were included in the study, and underwent an
investigation of demographic data, a standardized physical examination, ocular fundus examination, and laboratory
analyses. The minimum criterion for diagnosis of diabetic retinopathy was the presence of at least one microaneurysm.
Results: Of 619 subjects, 208 eligible subjects (122 women) with FINDRISC score≥ 9 were included in the study. The
mean age was 69.2 ± 8.5 years. Diabetic retinopathy was detected in 31 subjects, and the prevalence of diabetic
retinopathy in subjects with high risk for diabetes was 14.9%. In binary logistic regression analysis, risk factors associated
with diabetic retinopathy were history of impaired glucose regulation [odds ratio (OR), 7.194; 95% confidence interval
(CI): 1.083, 47.810], higher hemoglobin A1c (HbA1c; OR, 2.912; 95% CI: 1.009, 8.402), higher two-hour postprandial plasma
glucose level (OR, 1.014; 95% CI: 1.003, 1.025), and presence of microalbuminuria (OR, 5.387; 95% CI: 1.255, 23.129).
Conclusions: Diabetic retinopathy was prevalent in a high-risk Chinese population from Guangzhou. Histories of
impaired glucose regulation and microalbuminuria were strong risk factors for diabetic retinopathy.
Keywords: Finnish diabetes risk score, People with high risk for diabetes, Diabetic retinopathy, Prevalence, Risk factorsBackground
Diabetic retinopathy (DR) is a common chronic micro-
vascular diabetic complication, and it is the leading cause
of visual impairment among working adults in the Western
world [1]. Apart from visual morbidity, the presence of DR
may indicate microcirculatory dysfunction in other organ
systems [2,3]. Therefore, investigating the prevalence of
DR is important. The prevalence of diabetes mellitus (DM)
and prediabetes increases with increasing age. The preva-
lence of prediabetes among Chinese adults aged over 45
years was dramatically higher than in those aged between
20 and 30 years [4]. However, type 2 diabetes (T2DM) is
often not diagnosed until complications appear. Jia et al.* Correspondence: dehongcaizj@163.com
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reproduction in any medium, provided the or[5] showed that the prevalence of DR in the Chinese predi-
abetic population was 2.5%, and Lee et al. [6] showed that
the prevalence of diabetic retinopathy was 18.2% among
recently diagnosed diabetic patients (diabetic duration ≤ 1
year) in Hong Kong, China.
Lifestyle plays an important role in the development of
DR [7], and the lifestyle of Guangzhou is different from
that of other cities. The Cantonese prefer eating rice por-
ridge, but not spicy foods. The individual postprandial
blood glucose level dramatically increases after eating rice
porridge in a short time period, which increases the burden
of pancreatic island beta (β cell function. Chaiyasit et al.
[8] reported that people receiving capsicum had lower
plasma glucose levels and higher plasma insulin levels than
people in the placebo group. Capsaicin may be a useful
phytochemical for attenuating obesity-related complica-
tions, such as diabetes [9]. However, the prevalence of DRtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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betes in Guangzhou.
The Finnish Diabetes Risk Score (FINDRISC) question-
naire is a fast, simple, inexpensive, noninvasive, and reli-
able tool to identify individuals with high risk for diabetes,
and it has been widely used in different countries for iden-
tification of diabetic high-risk individuals [10-21]. In the
present study, we focused on people aged over 45 years,
and used the FINDRISC to identify individuals with high
risk for diabetes. We then evaluated the prevalence of DR
and associated risk factors.
Methods
Study population and design
A total of 650 subjects, aged over 45 years without
known diabetes, were randomly recruited from five com-
munities in Guangzhou between July 2009 and May
2010. Exclusion criteria were known DM, cancer, hepatic
failure, renal failure, severe psychiatric disturbance, and
any other systemic medical condition. Thirteen subjects
were excluded from the study. All 637 subjects were in-
vited to complete the FINDRISC questionnaire, which
contained questions about age, body mass index (BMI)
and waist circumference, family history of diabetes, his-
tory of antihypertensive drug treatment and impaired
glucose regulation (IGR), physical activity, and daily con-
sumption of fruits or vegetables. Eighteen subjects failedDong Xiao Nan 
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Figure 1 Flowchart of the samples collected.to complete the FINDRISC questionnaire, and the study
response rate was 97.2% (619/637). Among 619 subjects,
208 subjects with FINDRISC score ≥ 9 were included in
the study. A total of 208 included subjects received a
screening for DR, a standard oral glucose tolerance test
(OGTT), a physical examination (height, weight, waist cir-
cumference, hip circumference, and blood pressure), a col-
lection of blood samples to determine the level of fasting
plasma glucose (FPG), two-hour postprandial plasma glu-
cose (2hPG) levels, glycated hemoglobin (HbA1c) levels,
high-density lipoprotein cholesterol (HDL-C) concentra-
tion, low-density lipoprotein cholesterol (LDL-C) levels,
total cholesterol (TC), triglycerides (TG), and a collection
of first morning urine to determine the level of urinary al-
bumin. The study protocols were conducted in accordance
with the tenets of the Declaration of Helsinki and ap-
proved by the Medical Ethics Committee of ZhuJiang
Hospital of Southern Medical University. All patients pro-
vided written, informed consent (Figure 1).
Anthropometric and laboratory measurements
Weight was measured using a balance-beam scale with
clothing included. Height was measured using the clinic
stadiometer, with the Frankfort plane held horizontal. The
BMI was calculated as weight (kg) divided by squared
height (m2). Waist circumference was measured at the









Excluded by exclusion 
criteria (n=13)
ed to fill in 
tionnaire
Excluded for incompletely 













Wang et al. BMC Public Health 2013, 13:633 Page 3 of 7
http://www.biomedcentral.com/1471-2458/13/633crest, and hip circumference was measured at the max-
imum circumference over the buttocks. Blood pressure
was the average of three measurements obtained by a
sphygmomanometer at 2-min intervals.
FPG and 2hPG were measured by the glucose oxidase
method. HbA1c was measured by high-performance liquid
chromatography (HLC-723G7, Tosoh, Tokyo, Japan). TC,
TG, HDL-C, and LDL-C were measured by enzymatic
methods. The urinary albumin level was measured by
quantitative immunoturbidimetry (BN Prospect, Siemens,
Berlin, Germany).
Retinal photography and retinopathy assessment
Non-stereoscopic 45° photographs of the posterior pole
were taken from both eyes of each subject obtained by a
non-mydriatic fundus photographic instrument (D80,
Canon, Tokyo, Japan). The fundus photographs were ex-
amined by two trained and experienced ophthalmologists.
The minimum criterion for diagnosis of DR was the pres-
ence of at least one microaneurysm [22]. Retinopathy
grading was based on the results of the worst eye, and the
retinopathy severity score was assigned according to
the International Clinical DR Disease Severity Scale [23]
as follows: Grade 0, no abnormalities; Grade 1, mild non-
proliferative retinopathy (microaneurysm only); Grade 2,
moderate non-proliferative retinopathy (more than just
microaneurysms, but less than Grade 3); Grade 3, severe
non-proliferative retinopathy; Grade 4, proliferative retin-
opathy. Vision-threatening retinopathy (VTR) was defined
as the presence of severe non-proliferative retinopathy,
proliferative retinopathy, or clinically significant macular
edema. All photographs were gradable, and the assess-
ments of DR by two ophthalmologists were consistent.Definitions
The diagnosis of DM and IGR were previously defined
based on the 1999 World Health Organization (WHO)
diagnostic criteria [24]. IGR included impaired fasting glu-
cose (6.1 mmol/L ≤ FPG < 7.0 mmol/L) as well as impaired
glucose tolerance (7.8 mmol/L ≤ 2hPG < 11.1 mmol/L).
Diabetes and IGR were determined based on OGTT. Pre-
diabetes was defined as either impaired fasting glucose or
impaired glucose tolerance. Hypertension was diagnosed
as systolic blood pressure (SBP) ≥ 140 mm Hg and/or dia-
stolic blood pressure (DBP) ≥ 90 mm Hg at examinations,
and hypertension was also defined if the participant had a
previous physician diagnosis [25]. Microalbuminuria was
diagnosed as the urinary albumin concentration ≥ 30 mg/L
and <300 mg/L.
Statistical analysis
All analyses were performed using SPSS software version
13.0. Normally distributed and continuous variables werepresented as mean ± standard deviation. Categorical vari-
ables were expressed as percentages, and the χ2 test was
used for comparisons of proportions. The basic character-
istics of the individuals with and without DR were com-
pared using the Independent-Samples t-test for normally
distributed and continuous variables. Binary logistic re-
gression was used to assess the associations between DR
and the other parameters evaluated. Odds ratios (OR) and
95% confidence intervals (95% CI) were calculated. The A
value of p <0.05 was considered statistically significant
(two-tailed).Results
Clinical characteristics of the study population
All 619 subjects completed the FINDRISC questionnaire,
208 subjects (86 males) with FINDRISC score ≥ 9 were in-
cluded in the study, and the mean age was 69.2 ± 8.5 years.
Compared with subjects without DR (Table 1), subjects
with DR had higher HbA1c, FPG, and 2hPG levels, higher
FINDRISC scores, higher urinary albumin levels, higher
ratios of microalbuminuria, and history of IGR.
Among 208 subjects with a FINDRISC score ≥ 9, 55 sub-
jects (26.4%) had DM, 84 subjects (40.4%) had IGR, and
69 subjects (33.2%) had normal glucose tolerance (NGT).
There was no significant difference in prevalence of DR
among five communities (p = 0.979).Prevalence of DR
Among 208 included subjects with a FINDRISC score ≥
9, 27 had mild non-proliferative DR, two had moderate
non-proliferative DR, one had severe non-proliferative
DR, one had proliferative DR, and the total prevalence
of DR was 14.9%. The prevalence of VTR was 1.4%.
As shown in Table 2, the prevalence of DR increased
with increasing FINDRISC score (p = 0.041). The preva-
lence of patients with FINDRISC scores ≤ 10, ≤ 12,
and > 12 was 8.2%, 20.3%, and 21.2%, respectively. The
prevalence of DR in subjects with DM was dramatically
higher than in subjects without DM (38.2% vs. 6.5%, p <
0.001). The prevalence of DR in subjects with DM was
also dramatically higher than in subjects with IGR
(38.2% vs. 7.1%, p < 0.001). However, there was no sig-
nificant difference between subjects with IGR and sub-
jects with NGT (7.1% vs. 5.8%, p = 0.995).
Compared with subjects without history of IGR
(Table 2), subjects with history of IGR had higher
prevalence of DR (47.1% vs. 12.0%, p = 0.001). Com-
pared with subjects without microalbuminuria, subjects
with microalbuminuria had higher prevalence of DR
(38.5% vs. 11.5%, p = 0.001). The prevalence of DR in
subjects with hypertension was slightly higher than in
subjects without hypertension. However, there was no
Table 1 Clinical characteristics of the study population
With DR (n = 31) Without DR (n = 177) p value
Age (years) 69.84 ± 7.90 69.06 ± 8.57 0.636
Gender 0.472
Male 11 (35.5%) 75 (42.4%)
Female 20 (64.5%) 102 (57.6%)
Body mass index (kg/m2) 27.31 ± 3.06 26.49 ± 3.14 0.181
Waist circumference (cm) 90.10 ± 7.03 89.66 ± 7.92 0.774
Hip circumference (cm) 100.74 ± 6.21 99.42 ± 6.55 0.296
HbA1c (%) 6.54 ± 1.38 5.59 ± 0.59 0.010
FPG (mmol/L) 6.97 ± 2.34 5.70 ± 0.94 0.005
2hPG (mmol/L) 13.71 ± 5.24 8.95 ± 3.36 <0.001
Systolic blood pressure (mm Hg) 139.23 ± 17.24 139.88 ± 19.58 0.861
Diastolic blood pressure (mm Hg) 80.39 ± 10.42 80.38 ± 10.56 0.997
Hypertension 26(83.9%) 137(77.4%) 0.420
Total cholesterol (mmol/L) 5.62 ± 1.17 5.23 ± 1.47 0.165
Triglycerides (mmol/L) 2.52 ± 2.45 2.23 ± 1.66 0.408
HDL-cholesterol (mmol/L) 1.36 ± 0.32 1.40 ± 0.33 0.545
LDL-cholesterol (mmol/L) 3.57 ± 0.83 3.47 ± 1.00 0.580
Urine albumin (mg/L) 13.9 (11.2-30.3) 11.5 (11.2-15.8) 0.022
Microalbuminuria 10(32.3%) 16(9.0%) <0.001
Family history of diabetes mellitus 2(6.5%) 9(5.1%) 0.670
History of impaired glucose regulation 8(25.8%) 9(5.1%) 0.001
History of antihypertensive drug treatment 18(58.1%) 98(55.4%) 0.780
Physical activity (≥ 4 hours per week) 17(54.8%) 100(56.5%) 0.864
Daily consumption of fruits or vegetables 25(80.6%) 129(72.9%) 0.363
The FINDRISC score 12.06 ± 2.56 11.08 ± 2.14 0.023
DR diabetic retinopathy, FINDRISC Finnish diabetes risk score.
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vs. 11.1%, p = 0.420).
Risk factors for DR
In the present study, we carried out a full multivariable
binary logistic analysis using the enter method to evaluate
the risk factors for DR. The presence of DR was a
dependent parameter, and age, gender, family history of
DM, history of IGR, SBP, DBP, BMI, waist circumference,
hip circumference, HbA1c, FPG, 2hPG, TC, TG, HDL-
cholesterol, LDL-cholesterol, FINDRISC score, physical ac-
tivity, daily consumption of fruits or vegetables, history of
antihypertensive drug treatment, and microalbuminuria
were independent parameters. As shown in Table 3, the re-
sults of binary logistic analysis showed that history of IGR
(OR, 7.194; 95% CI: 1.083, 47.810) and macroalbuminuria
(OR, 5.387; 95% CI: 1.255, 23.129) were highly associated
with the development of DR. Every 1% increase in HbA1c
increased the risk for DR by 2.912 times (OR, 2.912; 95%
CI: 1.009, 8.402). Every 1 mmol/L increase in 2hPG in-
creased the risk for DR by 1.014 times (OR, 1.014; 95% CI:
1.003, 1.025).Discussion
Although the economy of China has made rapid progress
in the past few decades, the knowledge of health care re-
mains deficient, and not enough adequate emphasis is
placed on regular physical examinations. Moreover, more
than 50% of China’s population lives in rural communities,
where both the economic and medical conditions are
worse than in non-rural communities, and the people in
rural communities often do not go to hospital to see a
doctor until they have serious diseases. The prevalence of
diabetes increased from 0.67% in 1980 to 9.7% in 2008 in
the Chinese population, and that approximately 92.4 mil-
lion of the population 20 years of age or older had diabetes
[4]. However, in 60.7% of these cases, the diabetes was un-
diagnosed. Therefore, there is a failure to diagnose dia-
betes in China [4].
FINDRISC is a fast, simple, inexpensive, noninvasive,
but reliable tool used to identify individuals with high risk
for diabetes. It has been used in different countries for
identification of diabetic high-risk individuals [10-21].
Therefore, in the present study we used the FINDRISC
questionnaire to identify individuals with high risk for
Table 2 Prevalence of DR in subgroups
Prevalence of DR p value
FINDRISC score 0.041
Score≤ 10 8.2% (8/97)
10 < Score ≤12 20.3% (12/59)
Score >12 21.2% (11/52)
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Age (years) 0.588 1.019 0.952-1.090
Gender 0.110 2.959 0.781-11.210
Family history of diabetes 0.541 0.492 0.051-4.784
History of impaired glucose regulation 0.041 7.194 1.083-47.810
Body mass index (kg/m2) 0.752 0.949 0.686-1.312
Waist circumference (cm) 0.583 0.968 0.860-1.088
Hip circumference (cm) 0.083 1.147 0.982-1.339
History of antihypertensive drug treatment 0.641 0.747 0.219-2.548
Physical activity (≥ 4 hours per week) 0.195 0.443 0.129-1.517
Daily consumption of fruits or vegetables 0.608 1.446 0.353-5.922
FINDRISC score 0.901 1.021 0.739-1.411
HbA1c (%) 0.048 2.912 1.009-8.402
Fasting plasma glucose (mmol/L) 0.126 0.972 0.937-1.008
2 h postprandial plasma glucose (mmol/L) 0.015 1.014 1.003- 1.025
Systolic blood pressure (mm Hg) 0.855 0.997 0.965-1.030
Diastolic blood pressure (mm Hg) 0.480 1.024 0.959-1.092
Total cholesterol (mmol/L) 0.189 1.486 0.823-2.683
Triglycerides (mmol/L) 0.359 0.863 0.631-1.182
HDL-cholesterol (mmol/L) 0.449 0.489 0.077-3.117
LDL-cholesterol (mmol/L) 0.661 0.830 0.362-1.907
Microalbuminuria 0.023 5.387 1.255-23.129
FINDRISC Finnish diabetes risk score, HDL high-density lipoprotein,
LDL low-density lipoprotein.
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tigate whether the FINDRISC questionnaire could be used
to identify Chinese individuals with high risk for diabetes,
and what the optimal cut-off value of the FINDRISC score
is in the Chinese population. Therefore, a cut-off value of
the FINDRISC score ≥ 9 was used to identify subjects with
high risk for diabetes, which agreed with the research
findings of Lindström et al. [20] and Franciosi et al. [21].
Our studies showed that 139 subjects (66.8%) were
diabetic or prediabetic in 208 subjects with FINDRISC
scores ≥ 9. Therefore, our study partially confirmed that
the FINDRISC questionnaire was also a reliable tool to
identify individuals with high risk for diabetes in China.
Among 208 subjects with a FINDRISC score ≥ 9, the
prevalence of VDR was 1.4% and the overall prevalence of
DR was 14.9%. The prevalence of DR in the present study
was slightly lower than in a community-based investiga-
tion from Hong Kong of 3,510 patients with recently diag-
nosed diabetes (18.2%) [6]. However, the prevalence of DR
was dramatically higher than the prevalence rate reported
in other retinal epidemiological studies in patients with
newly diagnosed diabetes, such as the Shanghai Diabetic
Complications Study (SHDCS, 4.9%; [5]), the Chennai
Urban Rural Epidemiology Study (CURES, 5.1%; [26]), the
Australian Diabetes Obesity and Lifestyle Study (AusDiab,
6.2%; [27]), and the Chungju Metabolic Disease Cohort
Study (CMC study, 6.2%; [28]).
Although the FINDRISC score was not a risk factor of
DR (p = 0.901), the prevalence of DR increased with an in-
creasing FINDRISC score (p = 0.041). Because the sample
size in this study was small, only 208 subjects wereincluded in the study. Moreover, the distribution of the
FINDRISC score was uneven, which in 87.5% (182/208)
patients, was ≤ 13. We hypothesize that the small sample
size and the uneven distribution of the FINDRISC score
may partly explain why the FINDRISC score was not sig-
nificant in logistic analysis.
Studies have shown that HbA1c was a pivotal risk factor
for DR in patients with diabetes [5,22,28-32]. Consistent
with previous studies, the present study showed HbA1c
was an important risk factor for DR in subjects with high
risk for diabetes (OR, 2.912; 95% CI: 1.009 − 8.402). Kim
et al. [28] and Jia et al. [5] reported that 2hPG was an im-
portant risk factor for DR in Korean patients and Chinese
patients, respectively. Consistent with the above two stud-
ies, the present study indicated that 2hPG was a risk factor
for DR (OR, 1.014; 95% CI: 1.003 − 1.025).
Studies [31,33,34] have shown that microalbuminuria
was one of the risk factors associated with DR. Further-
more, Chen et al. [33] showed that in the Chinese popula-
tion a microalbuminuria threshold can predict the risk
for the development of DR in T2DM. In agreement with
previous studies, the present study showed that micro-
albuminuria was a strong risk factor for DR (OR, 5.387;
95% CI: 1.255, 23.129).
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plication, and many studies had shown that higher
plasma glucose level is an important risk factor for DR
[5,22,28-32]. Interestingly, the present study indicates
that the history of IGR is a strong risk factor for DR
(OR, 7.194; 95% CI: 1.083 − 47.810). There are several
reasons that may partly explain why the history of IGR
is a strong risk factor for DR, and why the history of
IGR is a much stronger risk factor than HbA1c or 2hPG
levels. First, T2DM is often not diagnosed until compli-
cations appear. Lee et al. [6] reported that the preva-
lence of DR in patients with recently diagnosed diabetes
was 18.2% in Hong Kong, China. Jia et al. [5] indicated
that the prevalence of DR in Chinese patients with predia-
betes and newly diagnosed diabetes was 2.5% and 4.9%, re-
spectively. Second, a long-term observation study showed
that approximately 70% of patients with IGR would finally
progress to diabetes. Consistent with the above study, the
present study showed that 52.9% (9/17) of patients with
history of IGR were diabetic. Third, compared with sub-
jects without a history of diabetes, patients with a history
of diabetes had a higher ratio of microalbuminuria, higher
HbA1c, and higher 2hPG levels. Further studies are
needed to clarify these findings.
Some studies indicated that hypertension was a risk fac-
tor for DR in diabetes [22,27,32,35,36]. The UK Prospect-
ive Diabetes Study (UKPDS) reported that intensive
control of blood pressure significantly reduced the inci-
dence of DR [37]. However, other studies indicated that
hypertension was not a risk factor for DR [5,31,38,39]. In
the present study, although hypertension was not a signifi-
cant risk factor for DR, the prevalence of DR in subjects
with hypertension was slightly higher than in subjects
without hypertension (16.0% vs. 11.1%, p = 0.420).
The present study used the FINDRISC questionnaire
to identify individuals with high risk for diabetes and
partly confirmed that it also was a reliable tool to iden-
tify individuals with high risk for diabetes in a Chinese
population. In addition, microalbuminuria and the his-
tory of IGR were found to be risk factors for DR in the
Chinese population with high risk for diabetes.
The limitations of our study should be noted. First, it was
a cross-sectional investigation and the sample size was
small. Second, the minimum criterion for diagnosis of DR
was the presence of at least one microaneurysm. However,
microaneurysm is not pathognomonic for diabetes mellitus.
This may also occur in hypertension or other diseases, and
hypertension and diabetic retinopathy share a number of
similar morphological features, especially at their early
stages [40]. Therefore, the estimated prevalence of DR may
be incorrect and slightly high. Third, we used 45 photo-
graphs of the central fundus to assess and diagnose DR, ra-
ther than fundus fluorescein angiography. Thus, individuals
with DR, especially at an early stage, may not be diagnosed.Conclusions
In summary, the FINDRISC questionnaire may also be a
reliable tool to identify individuals with high risk for
diabetes in China. The prevalence of DR was high in a
Chinese population at high risk for diabetes. Compared
with subjects with low FINDRISC scores, the prevalence
of DR in subjects with high FINDRISC scores was dra-
matically higher. The history of IGR and the presence of
microalbuminuria were strong risk factors for DR in the
Chinese high-risk population. Risk factors also included
higher HbA1c and 2hPG levels. As metabolic disorders
are controllable, using the FINDRISC questionnaire to
identify individuals with high risk for diabetes, regular
screening for diabetes and DR in individuals with high
FINDRISC scores, IGR, or microalbuminuria, may reduce
the number of individuals who develop diabetes or DR.
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